Product Details
Atectura Breezhaler
Indacaterol Acetate + Mometasone Furoate150 mcg + 160 mcg
Powder for Inhalation
Capsule
DIN/PIN/NPN
02498707
Manufacturer
Novartis Pharma Canada Inc.
Formulary Listing Date
2022-02-28
Unit Price
1.3419
Amount MOH Pays
1.3419
Coverage Status
Limited Use Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
R03AK14
Interchangeable Products
NOLU Clinical Criteria
| LU Code | Auth. Period | Clinical Criteria |
|---|---|---|
| 626 | Indefinite | For once-daily maintenance treatment of asthma in patients aged 12 years and older with reversible obstructive airways disease |